Crystal Research CEO Jeffrey Kraws Appointed Chairman of the Board, Synthetic Biologics (SYN-NYSE Amex)
ANN ARBOR, Mich., May 11, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (SYN-NYSE Amex), a developer of ...
Jeff Kraws Weighs In on Supreme Court Victory for Generic Drug Makers
Yesterday, Crystal Research CEO Jeffrey Kraws and NPR's correspondent Yuki Noguchi discussed the impact of a ...
Neonode (NEON-OTC.BB) is Changing Your Touchscreen
Neonode Inc. (NEON.OB) is set to report fourth quarter and year-end 2011 financials on Tuesday, March 13, ...
Authentidate Holding Corp. (ADAT) Second Quarter FY 2012 Update
Crystal Research continued its coverage of Authentidate Holding Corp. (ADAT-NASDAQ) with the publication of a ...
Independent Equity Research Report on T3 Motion, Inc. (TTTM)
Crystal Research has initiated coverage on T3 Moton, Inc. (TTTM-NYSE Amex) with the publication of a 56-page ...
Independent Equity Research Report on LRAD Corp. (LRAD-NASDAQ)
Crystal Research has initiated coverage on LRAD Corp. (LRAD-NASDAQ) with the publication of a 64-page ...
APDN's Technology Could Prevent Cheating on Standardized Tests
Applied DNA Sciences, Inc. (APDN-OTC.BB) announced today that it was invited by the Chairman of the New York ...
Healthcare Conferences and News: Week of 1/9 to 1/13
This has been a big week for healthcare and biotech.
APDN’s Anti-Counterfeiting Technology Addresses New Federal Legislation
A significant opportunity has arisen for Applied DNA Sciences (APDN-OTC) and its anti-counterfeiting and ...
Quarterly Update Issued on GenSpera, Inc.
Today, we published a Quarterly Update on GenSpera, Inc., a biotechnology company developing targeted ...
Unilife to report 2Q FY 2011 financial results in the U.S. on Feb. 14
After market close today, Crystal Research published a business update on Unilife Corp. (UNIS-NASDAQ). Beyond ...
Out with the old and in with the new…
This morning, we at Crystal Research debuted a new Research Library webpage. The new page is designed to be ...
Mid-Week News Highlights (12/6-12/8) from CRA’s Coverage Universe
News from our coverage universe this week includes Johnson & Johnson’s bid to buy Crucell for $2.3 ...